X

Trial Profile

The effect of Lixisenatide on triacylglycerol and glucose metabolism in patients with type 2 diabetes

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lixisenatide (Primary)
Indications Type 2 diabetes mellitus
Focus Pharmacodynamics; Pharmacokinetics

Most Recent Events

11 Sep 2018 Results published in the Journal of Clinical Endocrinology and Metabolism
13 Jun 2017 Results of effects of lixisenatide on postprandial lipoprotein kinetics (n=8) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
13 Jun 2017 Results assessing action of lixisenatide on mixed meal disposition presented at the 77th Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com